Apr 08, 2021 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the KemPharm, Inc. webcast and conference call. (Operator Instructions) I would now like to hand the conference over to your speaker for today, Jason Rando with Tiberend Strategic Advisors. You may begin.
Jason Rando - Tiberend Strategic Advisors, Inc. - COO & EVP
Good afternoon, and thank you for joining today's call to discuss the amendment to the license agreement with an affiliate of Gurnet Point Capital.
Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time including, but not limited to, statements about KemPharm's expectations regarding future operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially. KemPharm disclaims any obligation to update or revise its forward-looking
KemPharm Inc to Discuss the Amendments to License Agreement - Conference Call Transcript
Apr 09, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers